Literature DB >> 20182376

Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.

Adam J Singer1, Steve A McClain, Breena R Taira, Jean Rooney, Nicole Steinhauff, Lior Rosenberg.   

Abstract

Deep burns are associated with the formation of an eschar, which delays healing and increases the risk of infection. Surgical debridement of the eschar is, at present, the fastest means to achieve an eschar-free bed, but the process can not differentiate between the viable tissue and the eschar and follow the minute irregularities of the interface between the two. We evaluated the efficacy and selectivity of a novel enzymatic bromelain-based debriding agent, Debrase Gel Dressing (Debrase), in a porcine comb burn model. We hypothesized that Debrase would result in rapid debridement of the eschar without adverse effects on the surrounding uninjured skin. This is a prospective, controlled, animal experiment. Five domestic pigs (20-25 kg) were used in this study. Sixteen burns were created on each animal's dorsum using a brass comb with four rectangular prongs preheated in boiling water and applied for 30 seconds, resulting in four rectangular 10 x 20 mm full-thickness burns and separated by three 5 x 20 mm unburned interspaces representing the zone of stasis. The burned keratin layer (blisters) was removed, and the burns were treated with a single, topical, Debrase or control vehicle application for 4 hours. The Debrase/control was then wiped off using a metal forceps handle, and the burns were treated with a topical silver sulfadiazine (SSD). The wounds were observed, and full-thickness biopsies were obtained at 4 and 48 hours for evidence of dermal thickness, vascular thrombosis, and burn depth, both within the comb burns and the unburned interspaces in between them. Chi-square and t tests are used for data analysis. A single 4-hour topical application of Debrase resulted in rapid and complete eschar dissolution of all the burns in which the keratin layer was removed. The remaining dermis was thinner (1.1 +/- 0.7 mm) than in the control burns (2.1 +/- 0.3 mm; difference 0.9 mm [95% confidence interval: 0.3-1.4]) and was viable with no injury to the normal surrounding skin or to the unburned interspaces between the burns, which represents the zone of stasis. In control burns, the entire thickness of the dermis was necrotic. At 48 hours, Debrase-treated areas were found partially desiccated under SSD treatment. The unburned interspaces demonstrated partial-thickness necrosis in two third and full-thickness necrosis in one third of wounds. In contrast, full-thickness necrosis was noted in all control interspaces (P = .05). In a porcine comb burn model, a single, 4-hour topical application of Debrase resulted in rapid removal of the necrotic layer of the dermis with preservation of unburned tissues. At 48 hours, SSD treatment resulted in superficial tissue damage and partial preservation of the unburned interspaces.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20182376     DOI: 10.1097/BCR.0b013e3181d0f4d4

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  13 in total

1.  Does Platelet-Rich Fibrin Enhance Healing Of Burn Wounds? Our First Experiences And Main Pitfalls.

Authors:  A Schulz; J L Schiefer; P C Fuchs; C H Kanho; N Nourah; W Heitzmann
Journal:  Ann Burns Fire Disasters       Date:  2021-03-31

2.  Minimally invasive burn care: a review of seven clinical studies of rapid and selective debridement using a bromelain-based debriding enzyme (Nexobrid®).

Authors:  L Rosenberg; Y Shoham; Y Krieger; G Rubin; F Sander; J Koller; K David; D Egosi; R Ahuja; A J Singer
Journal:  Ann Burns Fire Disasters       Date:  2015-12-31

Review 3.  Current concepts on burn wound conversion-A review of recent advances in understanding the secondary progressions of burns.

Authors:  Ara A Salibian; Angelica Tan Del Rosario; Lucio De Almeida Moura Severo; Long Nguyen; Derek A Banyard; Jason D Toranto; Gregory R D Evans; Alan D Widgerow
Journal:  Burns       Date:  2016-01-17       Impact factor: 2.744

4.  Enzymatic escharolysis with nexobrid® on partial thickness burn wounds: pre- and post-debridement histological assessment.

Authors:  A Di Lonardo; V Nardini; M De Rosa; C Pascone; A Graziano; A M Criscuoli; S Ciappi
Journal:  Ann Burns Fire Disasters       Date:  2018-03-31

5.  Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns.

Authors:  Stefan Bohr; Suraj J Patel; Keyue Shen; Antonia G Vitalo; Michael Brines; Anthony Cerami; Francois Berthiaume; Martin L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model.

Authors:  Stefan Bohr; Suraj J Patel; Dhruv Sarin; Daniel Irimia; Martin L Yarmush; Francois Berthiaume
Journal:  Wound Repair Regen       Date:  2012-10-30       Impact factor: 3.617

7.  Bromelain-based enzymatic debridement of chronic wounds: A preliminary report.

Authors:  Yaron Shoham; Yuval Krieger; Eran Tamir; Eldad Silberstein; Alexander Bogdanov-Berezovsky; Josef Haik; Lior Rosenberg
Journal:  Int Wound J       Date:  2018-04-25       Impact factor: 3.315

8.  Secondary Burn Progression Mitigated by an Adenosine 2A Receptor Agonist.

Authors:  Nathan Haywood; Matthew R Byler; Aimee Zhang; Evan P Rotar; Dustin Money; Sarah E Gradecki; Huy Q Ta; Morgan Salmon; Irving L Kron; Victor E Laubach; J Hunter Mehaffey; Mark E Roeser
Journal:  J Burn Care Res       Date:  2022-01-05       Impact factor: 1.845

9.  In vitro performance of free and encapsulated bromelain.

Authors:  Janaína Artem Ataide; Letícia Caramori Cefali; Mariana Cecchetto Figueiredo; Lúcia Elaine de Oliveira Braga; Ana Lúcia Tasca Gois Ruiz; Mary Ann Foglio; Laura Oliveira-Nascimento; Priscila Gava Mazzola
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

10.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.